These authors FZ, JL, HX and YZ have contributed equally to this work. Moreover, high expression of AFAP1-AS1 was associated with the clinicopathological features and cancer progression. In this review, we sum up the current studies on the characteristics of AFAP1-AS1 in the biological function and mechanism of human cancers.
| INTRODUCTION
Nowadays, cancer is one of the major causes of death all over the world. 1, 2 According to mortality data collected by the National Center for Health Statistics, it is estimated that 1 688 780 new cancer cases and 600 920 cancer deaths will take place in the United States in 2017. 3 In order to fight against cancer effectively, we should make a great effort to find more precise diagnostic biomarkers and effective therapeutic targets.
Recently, increasing evidence has shown that the non-coding portion of the genome has a crucial functional importance in both normal physiology and diseases. [4] [5] [6] Long non-coding RNAs (lncRNAs), a group of non-protein-coding RNAs with more than 200 nucleotides in length, play a vital role in regulating significant cellular functions, including cell proliferation, differentiation, apoptosis, invasion, metabolism, developmental timing and immune responses. [7] [8] [9] [10] [11] [12] However, mutation of lncRNAs will cause cancer initiation and promote the metastasis of malignancy. [13] [14] [15] For instance, lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was first found in lung cancer metastasis. Many studies had demonstrated that lncRNA MALAT1 was overexpressed in various cancer, and it might act as a potential biomarker and therapeutic target in cancer treatment. [16] [17] [18] LncRNA MALAT1 might function as an oncogene through controlling alternative splicing process in breast cancer, influencing the expression of N-cadherin and E-cadherin in bladder cancer, combining with a multifunctional RNA-binding protein in colorectal cancer (CRC) and osteosarcoma. [19] [20] [21] [22] LncRNA HOX antisense intergenic RNA (HOTAIR)
induced cancer invasion and metastasis by regulating PRC2 target genes in breast cancer and epithelial-mesenchymal transition (EMT) programme in gastric cancer (GC). 23, 24 LncRNA H19 was upregulated in GC and associated with miR-675, p53 and Isthmin1 that improved cells proliferation, migration and invasion. [25] [26] [27] [28] [29] Among so many cancerrelated lncRNAs, actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) was initially discovered in oesophageal adenocarcinoma in 2013. 30 Then, numerous recent studies had focused on lncRNA AFAP1-AS1 and demonstrated that it was upregulated in many cancers and played an important role in tumour progression. A meta-analysis had shown that high expression of AFAP1-AS1 in human cancers was closely related to poor clinical outcome such as lymph node metastasis and distant metastasis. 31 Hence, we chose it as the main research object to summarize its characteristics in the biological function and mechanism of human cancers.
| IDENTIFICATION OF AFAP1-AS1
Actin filament-associated protein 1 (formerly AFAP-110), an actin Using siRNA to impair the expression of AFAP1-AS1 inhibited cell proliferation, migration and invasion and induced cell apoptosis through regulating related genes or signalling pathways. 30, 35, [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] In this review, the related clinicopathological characteristics and molecular functions of this lncRNA in cancers are presented in Tables 1   and 2 .
| AFAP1-AS1 IN VARIOUS CANCERS

| Oesophageal cancer
Oesophageal cancer is the eighth most frequent types of cancer and is the sixth leading cause of tumour-related death all over the world. 59, 60 There are 2 primary histological subtypes of oesophageal cancer, including oesophageal adenocarcinoma (OAC) and oesophageal squamous cell carcinoma (OSCC). 61 
| Pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma, one of the most aggressive solid malignancies, is the fourth leading cause of cancer-related deaths all over the world. 66, 67 PDAC is characterized by a fatal disease with early metastasis and resistance to chemotherapy and radiation therapy. 7, 68 Although the study of PDAC has made rapid progress in the last decades, the 5-year survival rate of PDAC patients is still only around 5%-7%. 69, 70 Therefore, it is crucial to identify reliable biomarkers for early diagnosis of PDAC patients. T A B L E 1 Overexpression of actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) is associated with clinicopathological features
| Nasopharyngeal carcinoma
Nasopharyngeal carcinoma, a unique disease to Southeast Asia, is associated with the Epstein-Barr virus (EBV). 82, 83 About 75%-90% of NPC cases are diagnosed at advanced stages due to the non-specific symptoms at an early stage and poor accessibility for physical examination. 84, 85 The main clinical treatment of NPC is radiotherapy over the past few decades, but many patients finally die because of recurrence and distant metastasis. 86, 87 Therefore, it is essential to find therapeutic targets and prognostic biomarkers for accurate early diagnosis of high-risk populations and evaluation of NPC treatment. T A B L E 2 Functional characterization of the actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) in tumours 
| Lung cancer
Lung cancer is the leading cause of cancer-related mortality all over the world. 88, 89 According to histopathological presentation, lung cancer is divided into 4 primary histological subtypes: small cell lung cancer, squamous cell carcinoma (SCC), adenocarcinoma (ADC) and large cell carcinoma (LCC). 90 
| Ovarian cancer
Ovarian cancer (OC) is the third most widespread carcinoma of the female reproductive system. 104 Despite the advances in surgery, diagnostic method and new chemotherapy, OC mortality rate is still high because most patients are diagnosed at an advanced stage. [105] [106] [107] Therefore, it is exceedingly important to study its molecular mechanisms.
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| Colorectal cancer
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide. 104, 108 Although advanced treatments, involving the combination of surgery, radiation therapy, chemotherapy and targeted therapy, are utilized to improve the prognosis of CRC patients, the recurrence and metastasis of CRC are still unavoidable. 109, 110 The incidence and mortality of CRC will reduce by screening CRC from curable early stage, so we need to find a novel diagnostic and prognostic indicator for CRC.
Some experimental results proved that AFAP1-AS1 was aberrantly Taken together, these results suggest that AFAP1-AS1 produces oncogenic effects in BTC and may become an effective diagnostic and therapeutic target for BTC.
| Gastric cancer
Gastric cancer, the fourth most commonly diagnosed cancer, is one of the major causes of cancer-related death all over the world. 115, 116 Although surgery and chemotherapy for GC have made great progress, GC patients at an advanced stage remain a poor prognosis, having an extremely low 5-year survival rate. 117, 118 Thus, it is urgent to find a new biomarkers for diagnosis and prognosis of GC.
Guo et al 58 reported that AFAP1-AS1 was overexpressed in GC tissues and cells compared with corresponding normal counterparts. 
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